Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations.
about
Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South AfricaUnderstanding Adherence and Prescription Patterns Using Large-Scale Claims Data.A new taxonomy for describing and defining adherence to medicationsCost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.Adherence and resource use among patients treated with biologic drugs: findings from BEETLE studySystematic review and meta-analysis of vein cuffs for below-knee synthetic bypass.Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases.Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analysesCost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patientsAdherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community.Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data.Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.Systematic reviews: causes of non-adherence to P2Y12 inhibitors in acute coronary syndromes and response to intervention.Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy.Explanatory versus pragmatic trial-based economic evaluations: application to alternative therapies for burns.Adherence to biologic DMARD therapies in rheumatoid arthritis.The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Inclusion of compliance and persistence in economic models: past, present and future.Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.Markov modeling and discrete event simulation in health care: a systematic comparison.Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches.Predicting medication persistence to buprenorphine transdermal system.Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.Improving Realism in Clinical Trial Simulations via Real-World Data.Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis.Pharmacoeconomics
P2860
Q26766241-81FF6E2D-0B0F-42E4-918C-2CC8268A2147Q31031776-301390BA-549A-4271-A369-F41530E8C19BQ31054192-7C2D8C22-7B5B-4640-ABAE-251B59BD20DEQ33942472-CF52E131-DA1E-481C-B728-30066621C027Q34229494-CD1182A4-BB49-4E37-8F41-E61BB24C6C9CQ34278629-10A3A549-4340-4360-AC19-6F19D25B7390Q34598490-F3306096-4323-46EC-861B-08DC0F3A48FEQ35485247-B090CFD8-891B-4CA3-9A55-DDFA9C78D807Q35625741-6E8AD3B4-84B4-4EAA-8808-69A5BEDBD469Q36244228-BD32502F-52B4-4500-905B-F24846005130Q36266434-99117768-849A-4E42-A6D3-29D95C37CCEBQ36356513-756F9C21-0461-4F5A-85F1-17AC8909FCE6Q36581576-6526851D-3661-469E-9F5A-C4D7214F46EEQ37355978-6DB6E4C7-1FD2-49D8-941E-6174CD6EB36CQ37538469-9DED73B5-2759-411D-B6A1-8AD63ED50C3CQ37685134-5A1FC27E-C8CB-41F4-B1D2-B74241F0CE2FQ37777418-B0AE9857-1E18-4EC6-847F-24E22C3A5DB6Q37998122-B4EC9C5A-9DA3-4882-A12A-3E6050DF78B9Q38048913-CF3B56F9-7C0E-48EC-BBAC-9EA49E6034EDQ38205728-0EECDD04-AD5A-4D42-B73D-A767CB02E9F1Q38207748-AA1A6DA4-9631-4367-85F0-664C047B61C6Q38692558-458E2CE9-B6C1-46C5-ADD5-1273E47B98CBQ45163862-93D8FBA5-E616-4971-9AD5-E626F802F268Q45331432-F2A5CB12-CE7E-4569-A90A-AD790F6AD2CAQ47150754-1B0E59E9-7289-4F32-A91C-FE84E8FBCEBCQ48631709-54842C7E-298B-4C7D-88D6-66535CF1AC05Q57774074-0E2C7CAD-A32C-4019-909A-845E638843BF
P2860
Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Methods for integrating medica ...... pharmacoeconomic evaluations.
@en
type
label
Methods for integrating medica ...... pharmacoeconomic evaluations.
@en
prefLabel
Methods for integrating medica ...... pharmacoeconomic evaluations.
@en
P2093
P1433
P1476
Methods for integrating medica ...... pharmacoeconomic evaluations.
@en
P2093
International Society for Phar ...... ation Compliance Working Group
Joyce Cramer
Tamas Koncz
Warren Cowell
P304
P356
10.1111/J.1524-4733.2007.00205.X
P577
2007-11-01T00:00:00Z